# Trial of an Inactivated Yellow Fever Virus Vaccine

> **NCT05172544** · PHASE1 · COMPLETED · sponsor: **Najit Technologies, Inc.** · enrollment: 26 (actual)

## Conditions studied

- Yellow Fever

## Interventions

- **BIOLOGICAL:** HydroVax-002 YFV
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05172544
- **Lead sponsor:** Najit Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-13
- **Primary completion:** 2023-04-24
- **Final completion:** 2023-04-24
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05172544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05172544, "Trial of an Inactivated Yellow Fever Virus Vaccine". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05172544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*